{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:16:38Z","timestamp":1793052998560,"version":"4.5.0"},"reference-count":21,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: Hypermobile Ehlers\u2013Danlos syndrome (hEDS) is the most common subtype of Ehlers\u2013Danlos syndromes (EDS), a heterogeneous group of hereditary connective tissue disorders. The hallmark features of hEDS include generalized joint hypermobility (GJH), soft or velvety skin, and persistent joint pain. The molecular etiology of hEDS remains unknown, and diagnosis is primarily clinical. The updated diagnostic criteria for hEDS requires the fulfillment of three criteria: (1) GJH, (2) a combination of musculoskeletal and systemic manifestations consistent with a connective tissue disorder, and (3) the exclusion of alternative diagnoses. However, the exclusion process and the role of genetic testing have not yet been fully refined. Methods: This retrospective review utilized data from the Hereditary Connective Tissue Disorders (HCTD) patient registry at the University of Miami, which includes individuals evaluated at the HCTD Clinic using a standardized internal clinical and genetic protocol. We analyzed data from 907 patients referred for hEDS evaluation between June 2019 and December 2022. Results: Among these patients, 178 met the 2017 diagnostic criteria for hEDS. Genetic testing identified an alternative or additional diagnosis in 47 of these individuals (26.4%), with clinical implications requiring distinct management strategies. Conclusions: These findings underscore the importance of criterion three\u2014exclusion of alternative diagnoses\u2014and highlight the critical yet underutilized role of genetic testing in the assessment of joint hypermobility. Furthermore, the results suggest that hypermobility may present a shared phenotype across a spectrum of disorders, including inflammatory diseases, monogenic syndromes, and chromosomal abnormalities.<\/jats:p>","DOI":"10.3390\/genes16050530","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:50:43Z","timestamp":1746071443000},"page":"530","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hypermobile Ehlers\u2013Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-5186","authenticated-orcid":false,"given":"Irman","family":"Forghani","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Mount Sinai Medical Center of Florida, Miami Beach, FL 33140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"See","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, FL 33146, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"McGonigle","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami, Miami, FL 33146, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers-Danlos syndromes","volume":"175","author":"Malfait","year":"2017","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ajmg.c.31539","article-title":"A framework for the classification of joint hypermobility and related conditions","volume":"175","author":"Castori","year":"2017","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/dvdy.220","article-title":"Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes","volume":"250","author":"Gensemer","year":"2021","journal-title":"Dev. Dyn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajmg.a.63426","article-title":"Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center","volume":"194","author":"Ritelli","year":"2024","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4274\/balkanmedj.2018.1113","article-title":"Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome","volume":"36","author":"Forghani","year":"2019","journal-title":"Balk. Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e63857","DOI":"10.1002\/ajmg.a.63857","article-title":"Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker","volume":"197","author":"Ritelli","year":"2025","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajmg.c.31433","article-title":"The neuromuscular differential diagnosis of joint hypermobility","volume":"169","author":"Donkervoort","year":"2015","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_8","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2024, June 04). 1q21.1 Recurrent Deletion, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK52787\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-5-8","article-title":"A review of trisomy X (47,XXX)","volume":"5","author":"Tartaglia","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.fertnstert.2016.02.019","article-title":"Triple X syndrome and puberty: Focus on the hypothalamus-hypophysis-gonad axis","volume":"105","author":"Stagi","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ejhg.2010.184","article-title":"Phenotypic manifestations of copy number variation in chromosome 16p13.11","volume":"19","author":"Nagamani","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Stafford, C.F., and Sanchez-Lara, P.A. (2022). Impact of Genetic and Genomic Testing on the Clinical Management of Patients with Autism Spectrum Disorder. Genes, 13.","DOI":"10.3390\/genes13040585"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","article-title":"Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies","volume":"86","author":"Miller","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rheumatology\/40.2.202","article-title":"Pro-inflammatory interleukins in the synovial fluid of rheumatoid arthritis associated with joint hypermobility","volume":"40","author":"Punzi","year":"2001","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S127393","article-title":"Postural tachycardia syndrome: Current perspectives","volume":"14","author":"Wells","year":"2017","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_17","first-page":"1173","article-title":"Fatigue: An overview","volume":"78","author":"Rosenthal","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"ref_18","unstructured":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome, Board on the Health of Select Populations, and Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness, National Academies Press."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15420\/AER.2016.4.3","article-title":"Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes","volume":"5","author":"Akdis","year":"2016","journal-title":"Arrhythmia Electrophysiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology (2021). Guidance regarding gamete and embryo donation. Fertil. Steril., 115, 1395\u20131410.","DOI":"10.1016\/j.fertnstert.2021.01.045"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/5\/530\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:24:13Z","timestamp":1760030653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/5\/530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["genes16050530"],"URL":"https:\/\/doi.org\/10.3390\/genes16050530","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}